FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology. Echocardiography (EchoCG) is carried out with evaluation of parameters of right chambers of heart and at indicators: TAPSE 0.9–1.7 cm, RV FAC < 35%, RV EF < 45%, levosimendan 12.5 mg is intravenously infused at rate of 0.05–0.2 mcg/kg/min for 24–36 hours in the intensive care unit under continuous monitoring of systemic hemodynamics parameters; control echocardiography is performed 72 hours after the end of levosimendan infusion with assessment of functional parameters of right chambers of heart and with positive dynamics of TAPSE values; RV EF and FACFDK perform implantation of a left ventricular assist device.
EFFECT: method enables to prepare a patient with terminal heart failure for the left ventricular hemodynamic support mechanical device implantation, provides improved contractility of the right ventricle and thereby reduces the risk of a life-threatening complication, that is right ventricular failure.
1 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR OPTIMIZING TREATMENT OF HEART FAILURE IN PATIENTS WITH IMPLANTED ARTIFICIAL LEFT VENTRICLE | 2024 |
|
RU2838967C1 |
| METHOD FOR PREPARING PULMONARY CIRCULATION OF RECIPIENTS BEFORE PERFORMING HEART TRANSPLATION | 2017 |
|
RU2678686C1 |
| METHOD FOR PREVENTION OF LOW CARDIAC OUTPUT SYNDROME AND COMPLICATIONS THEREOF FOLLOWING CARDIAC VALVE REPLACEMENT | 2012 |
|
RU2512745C1 |
| METHOD OF ANAESTHESIA FOR CAESAREAN SECTION IN PREGNANT WOMEN WITH EISENMENGER SYNDROME | 2023 |
|
RU2823109C1 |
| METHOD FOR ASSESSING POSTOPERATIVE DECLINE IN RIGHT VENTRICLE CONTRACTILITY IN PATIENTS AFTER CORONARY BYPASS SURGERY WITH CARDIOPULMONARY BYPASS | 2014 |
|
RU2563958C1 |
| METHOD FOR PREDICTING IMPROVEMENT IN MYOCARDIAL CONTRACTILITY IN PATIENTS WITH CHRONIC HEART FAILURE AGAINST BACKGROUND OF MODULATION OF CARDIAC CONTRACTILITY | 2023 |
|
RU2806976C1 |
| METHOD FOR DETERMINING SITE FOR IMPLANTATION OF VENTRICULAR ELECTRODES OF CARDIAC CONTRACTILITY MODULATION DEVICE IN PATIENTS WITH CHRONIC HEART FAILURE | 2022 |
|
RU2806973C1 |
| METHOD OF DETERMINING LATENT SYSTOLIC DYSFUNCTION OF RIGHT VENTRICLE | 2022 |
|
RU2811760C1 |
| METHOD FOR OPTIMIZING PERIOPERATIVE PERIOD OF ELDERLY AND SENILE PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN SURGICAL TREATMENT OF LUNG CANCER | 2020 |
|
RU2757580C1 |
| METHOD FOR INDIVIDUAL SELECTION OF SUPPORTING DOSE OF LEVOSIMENDAN FOR TREATING ACUTE HEART FAILURE IN ELDERLY PATIENTS IN ACUTE PHASE OF MYOCARDIAL INFARCTION | 2015 |
|
RU2601666C1 |
